Related Experiment Video
Updated: Dec 7, 2025
05:58
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
Published on: August 16, 2024
3.6K
Application of Single-Cell Sequencing to Immunotherapy.
Kristin G Beaumont1, Michael A Beaumont1, Robert Sebra1
1Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Box 1498, New York, NY 10029, USA.
The Urologic Clinics of North America
|October 3, 2020
Summary
Single-cell analysis offers new insights into cancer immunotherapy by revealing hidden cell populations. This approach is particularly promising for understanding and treating heterogeneous urologic and prostate cancers.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Cancer is a complex, heterogeneous disease.
- Immunotherapy shows promise for cancer treatment.
- Urologic and prostate cancers exhibit significant heterogeneity.
Purpose of the Study:
- To review cancer immunotherapy through the lens of single-cell analysis.
- To highlight the potential of single-cell technologies in understanding cancer.
- To discuss advancements in single-cell analysis for immunotherapeutic development.
Main Methods:
- Review of current literature on single-cell analysis and cancer immunotherapy.
- Discussion of state-of-the-art technologies enabling single-cell resolution.
- Focus on applications in urologic and prostate cancer research.
Main Results:
- Single-cell analysis provides high resolution for identifying underappreciated cell populations.
- This high resolution aids in understanding cancer progression and treatment response.
- Potential exists for novel immunotherapeutic strategies based on single-cell findings.
Conclusions:
- Single-cell analysis is a powerful tool for advancing cancer immunotherapy.
- It offers unique insights into the heterogeneity of urologic and prostate cancers.
- Technological advancements are crucial for realizing the full potential of this approach.
